Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Approvals
Once-Weekly Eli Lilly (LLY) Diabetes Drug Wins FDA Approval 11/26/2014 6:03:00 AM
Bristol-Myers Squibb Company (BMY) Release: ELIQUIS Approved For Treatment Of Venous thromboembolic events (Deep Vein Thrombosis [DVT], Pulmonary Embolism [PE]) and prevention of recurrent DVT and PE 11/26/2014 7:47:18 AM
European Commission (EC) Approves Janssen-Cilag International NV (JNJ)'s Rezolsta 11/25/2014 5:48:11 AM
FDA Approves Valeant (VRX)'s Onexton Gel For Acne Treatment 11/25/2014 6:45:18 AM
Purdue Pharma L.P. Wins FDA Approval For Powerful Painkiller Hysingla 11/20/2014 12:56:24 PM
Ariad Pharmaceuticals, Inc. (ARIA) And Specialised Therapeutics Australia Announce Approval Of Iclusig (Ponatinib) In Australia 11/24/2014 9:38:04 AM
Health Canada Approves IMBRUVICA By Priority Review, Giving Physicians And Patients A Much-Needed Option In The Fight Against Chronic Lymphocytic Leukemia 11/19/2014 3:25:12 PM
(Pr)OTEZLA® (apremilast tablets), First In A New Class Of Oral Treatment, Receives Health Canada Approval For Plaque Psoriasis 11/18/2014 6:01:10 PM
Regeneron (REGN)'s Eylea Gets Japanese Nod For Macular Edema 11/18/2014 8:04:16 AM
Regeneron (REGN) Announces EYLEA (aflibercept) Injection Approved For The Treatment Of Diabetic Macular Edema (DME) In Japan 11/18/2014 1:56:06 PM
Celgene (CELG) Announces Swissmedic Approval Of REVLIMID® (Lenalidomide) For Treatment Of Patients With Relapsed Or Refractory 11/18/2014 12:51:56 PM
FDA Approves Roche (RHHBY)’s Avastin Plus Chemotherapy To Treat Women With Platinumresistant Recurrent Ovarian Cancer 11/17/2014 1:42:05 PM
FDA Approves Genzyme Corporation (GENZ)’s Lemtrada For MS 11/17/2014 6:06:30 AM
FDA Approves Genentech (RHHBY)’s Avastin (Bevacizumab) Plus Chemotherapy To Treat Women With Platinum-Resistant Recurrent Ovarian Cancer 11/17/2014 12:30:18 PM
Par Pharmaceutical, Inc. Announces First FDA Approval Of Vasostrict™ (Vasopressin Injection, USP) 11/12/2014 7:23:49 AM
1234567
//-->